EU nations struggle to full show vaccination solidarity

The European Union is struggling to show full vaccination solidarity among member nations after a week of negotiations over the distribution of extra doses exposed fissures

Via AP news wire
Friday 02 April 2021 08:12
Virus Outbreak Belgium EU Summit
Virus Outbreak Belgium EU Summit

The European Union is struggling to show complete coronavirus vaccination solidarity among member nations, after a week of negotiations over the distribution of extra doses exposed fissures on Friday.

Five EU nations that struggled most to get their vaccination drive going were given extra doses from an alliance of 19 other countries. Three nations weren't part of the deal, however, showing the difficulties of compromise politics when COVID-19 cases are surging again.

At an EU summit last week, Austrian Chancellor Sebastian Kurz criticized the allocation of shots in the 27-nation bloc, saying that some countries were receiving more than their fair share at the cost of others. EU leaders failed to agree on a correction mechanism, leaving it to their EU ambassadors.

Late Thursday, a deal was reached on how to distribute an early batch of 10 million Pfizer-BioNTech doses with Bulgaria, Croatia, Estonia Latvia and Slovakia receiving a proportionally large number of doses. Austria, along with the Czech Republic and Slovenia didn't get additional shots.

“We are grateful for the remarkable efforts" and solidarity of fellow EU member states, Latvian Prime Minister Krišjānis Kariņš said. He said the extra shots “will bring us closer to our common goal — a collective immunity across the EU.”

Under the joint procurement program set up by the European Commission, doses are allocated on a pro rata basis, but some nations are taking less than their share. A large majority of EU members think the system is working well, but said some nations made a mistake to focus on AstraZeneca shots instead of diversifying their vaccine portfolios.

AstraZeneca shots are cheaper and easier to handle than vaccines from Pfizer-BioNTech or Moderna.

Overall, the EU continues to lag well behind nations like the United Kingdom and United States when it comes to vaccinations.

___

Follow AP’s pandemic coverage at:

https://apnews.com/hub/coronavirus-pandemic

https://apnews.com/hub/coronavirus-vaccine

https://apnews.com/UnderstandingtheOutbreak

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in